HERE WE GO! $$$$$$$$$$$$$$$$$$$$$$$$ $Jim Nixon, the

New Post Public Reply Private Reply Replies (1) Message Board
toodles
375
HERE WE GO! $$$$$$$$$$$$$$$$$$$$$$$$

$Jim Nixon, the founder and CEO of $WCVC, decided to start making the product available after seeing the effect it had in treating his son’s multiple sclerosis.

https://www.thegrowthop.com/cannabis-news/own...t-marriage


“I started taking pills and was at the doctor’s often,” Jordan Nixon told Westword. “I used to get flare-ups, like, every six months. I lost vision one year, coordination and had pain shooting up and down my legs,” he said

All that changed when the owner of the cannabis company that Jordan Nixon used to work for offered him some CBD pills to see if they could help. “He said, ‘Oh, I heard some stories about M.S., why don’t you just try this?’ I did, and I had an MRI a few months later and there were drastic changes on the MRI.”

Three months after starting the pills, he claimed that his brain lesions had decreased in size so dramatically that his father wanted to spread the word the only way he knew how. “After seeing the benefits helping my son here, we wanted to share it with the world. We felt like we have a great vehicle with the restaurants to bring that on,” Jim Nixon said.

Instead of partnering with a cannabis company, the Nixons started one of their own and named it Illegal Brands. After plenty of experimentation, they decided to keep the offerings to CBD-infused water and 15 mg packages of CBD, which they sell for $2 each.

$WCVC Cannabinoid (CBD) Health Products List + Link
You can buy Illegal Brands products right now if you want!

https://www.illegalbrands.com/product-categor...-products/

Illegal Brands 30mg CBD Infused Water - Mango Bergamot
Mango Bergamot CBD Infused Water

MULTIPLE SCLEROSIS - Cannabidiol (CBD)

Spasticity is the main cause of disability in patients
with multiple sclerosis. Cannabinoids reduce
glutamate release, thereby regulating glutamatergic
excitability and consequently spasticity (23). In mice
models with autoimmune encephalomyelitis which
recreates multiple sclerosis in humans, CBD seemed
to ameliorate disease symptoms. The mechanisms
underlying the reduction in spasticity are the decrease
in pro-inflammatory mediators and activation of PPAR?
(peroxisome proliferator-activated receptor gamma,
also known as glitazone receptor) and PI3K-AKT-mTOR
pathway (regulator of cell cycle) (24).
The MUSEC trial (2012), a double-blind, placebocontrolled, phase III study, involving 279 patients,
assessed the effects of oral administration of a
standardized Cannabis sativa extract (0.8-1.8 mg CBD
and 2.5 mg THC) on spasticity, pain, but also sleep
quality in multiple sclerosis. The study revealed the
capacity of Cannabis sativa standardized extract
to alleviate muscle stiffness in multiple sclerosis.
Authors also concluded that there was an effective
pain remission in patients, especially in patients
having high baseline pain score (25). In a randomized,
placebo-controlled, crossover trial, Corey-Bloom et
al. (2012) showed that inhaled cannabis reduced the
treatment-resistant spasticity in mutiple sclerosis
(26). A placebo-controlled, double-blind, betweengroups study on 493 patients with progressive
multiple sclerosis, did not find any effect on disease
progression when receiving a daily oral cannabis
extract (standardized in 0.8-1.8 mg CBD and 2.5
mg THC), dose-adjusted for each patient to a
maximum of 28 mg of THC daily for ten weeks (27).
As noted elsewhere, 40-60% of individuals with
multiple sclerosis manifest some degree of cognitive



Cannabidiol (CBD) enhanced the hippocampal immune response and autophagy of APP/PS1 Alzheimer's mice uncovered by RNA-seq

https://www.sciencedirect.com/science/article...2052031377

Life Sciences
Volume 264, 1 January 2021, 118624

Alzheimer's disease (AD) is a central nervous system disease characterized by dementia, which has now become a major threat to global health. Cannabidiol (CBD) is a natural component extracted from the hemp plant and exhibits multiple mechanisms to improve the pathological process of AD in vitro and in vivo. However, its underlying molecular mechanism is still unclear. This study attempts to reveal its common mechanism through transcriptome sequence. We performed transcriptome sequence in the hippocampus of 6 month old APP/PS1 mice chronically treated with CBD for one month or 30 days. In addition, Aß plaques were investigated by Immunohistochemistry. Autophagosomes were observed by transmission electron microscopy and the expression of autophagy related proteins was examined by Western blot. GO_BP and KEGG enriched analysis showed that the immune system response was up-regulation significantly. Both KEGG pathway analysis and GSEA analysis showed that autophagy was significantly up-regulated. Finally, the autophagy of hippocampal neurons in APP/PS1 mice treated with CBD was significantly enhanced by transmission electron microscopy. This study illustrated that CBD may improve the pathological process of AD by enhancing immune system response and autophagy pathway.

https://www.sciencedirect.com/science/article...0520313771

Cannabis therapy in neurological disorders:
Recent advances and perspectives
https://farma.com.ro/articles/2020.4/RJPhP_2020_4_Art-01.pdf

$WCVC GETTING NOTING BUT GOOD REVIEWS!
ILLEGAL BURGER ON "YELPS" "TOP 10 BEST BURGERS IN COLORADO LIST"!
(ranked #9 burger in all Colorado!)

https://www.yelp.com/search?find_desc=Burgers...nver%2C+CO

https://www.yelp.com/biz/illegal-burger-capit...sq=Burgers

Illegal Burger Evergreen
4.4 OUT OF 5.0 (+88%
BASED ON > 413 Google reviews

$TRIPADVISOR" LISTS $ILLEGAL BURGER #3 BEST RESTAURAUT TO VISIT IN EVERGREEN COLARADO!
https://www.tripadvisor.ca/Restaurants-g33415...orado.html

OPEN YOUR OWN $WCVC "ILLEGAL BURGER" FRANCHISE TODAY!

Do you want to be a part of the first ever cannabis friendly food chain in America?

THIS IS YOUR OPUOUTUNITY!
(follow the link for details!!)


https://www.myfranchisehub.com/the-illegal-bu...unity.html


TOODLES

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 8

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 4

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 7

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 6

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 3

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 3

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 10

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 9

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 6

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 3

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Important Shareholder Investigations in Various Companies

Updated Category News Views 261

Overview of Current Shareholder Investigations Brodsky & Smith, a well-known litigation law firm, is actively reminding shareholders about various ongoing investigations involving Sealed Air Corporation, Movano Inc., Gulf Island Inc., and Denny's Corporation. If you are a shareholder interested in obtaining more information regarding these investigations, you can reach...

Continue Reading
Nykredit Announces Voluntary Tender Offer for Spar Nord Bank

Updated Category News Views 147

Nykredit Announces a Voluntary Public Tender Offer for Spar Nord Bank Nykredit Realkredit A/S, a prominent player in the Danish financial landscape, has publicly unveiled its plans for a voluntary tender offer directed at Spar Nord Bank A/S. This anticipated offer, which signals Nykredit's strategic expansion ambitions, seeks to acquire all available shares in Spar Nord...

Continue Reading
Big 5 Sporting Goods Embarks on New Growth Journey After Merger

Updated Category News Views 292

Big 5 Sporting Goods Corporation Announces Merger Completion Big 5 Sporting Goods Corporation (Nasdaq: BGFV), a well-established name in the sporting goods industry, has successfully completed its merger with a partnership composed of Worldwide Golf and Capitol Hill Group. This new chapter for Big 5 is expected to propel the company towards greater heights. Merger Details...

Continue Reading
UCB's BIMZELX® Data: A Game Changer for Arthritis Care

Updated Category News Views 132

UCB's Innovative Efforts in Arthritis Treatment UCB is making significant strides in the field of rheumatology, particularly with the release of new data regarding BIMZELX® (bimekizumab-bkzx) presented at the ACR Convergence 2024. This marks the first time the company has shared data specifically relating to psoriatic arthritis (PsA), non-radiographic axial...

Continue Reading
Mega Matrix Launches Captivating Urban Romance on FlexTV

Updated Category News Views 614

Engaging Romance Premieres on FlexTV Mega Matrix Inc. (NYSE American: MPU) has unveiled a captivating romantic miniseries titled A flash Marriage With The Billionaire Tycoon, streaming on its renowned short series platform, FlexTV. This adventurous drama dives into themes of love, responsibility, and the quest for personal redemption, showcasing the complicated lives of...

Continue Reading